36 computer-programmer-"the"-"IMPRS-ML"-"IMPRS-ML"-"Prof"-"BIP"-"EURAXESS" "UCL" Fellowship positions
Sort by
Refine Your Search
-
on neurodevelopment and mental health within the Children Growing up in Liverpool (C-GULL) programme. About you The successful candidate must have a PhD in molecular epidemiology (or similar), or equivalent working
-
] 3) A cover letter detailing the fellowship scheme(s) you are interested in being sponsored for, a timeline for application(s), and how you see yourself and your research programme fitting into
-
] 3) A cover letter detailing the fellowship scheme(s) you are interested in being sponsored for, a timeline for application(s), and how you see yourself and your research programme fitting into
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
This Bioinformatician position is ideal for an ambitious and highly motivated postdoctoral scientist who will be integral to innovative microbiome work within the Children Growing up in Liverpool (C-GULL) programme of
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and